What's new

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 3, Status: Authorised

Jun 17, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Reflection paper on use of real-world data in non-interventional studies to gene...

Next Article

What European defense is really looking for: Risk reduction and domestic continuity

Related Posts

Withdrawn application: Inaqovi, 06/11/2024

Withdrawn application: Inaqovi, 06/11/2024

Jun 17, 2025  0

Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Upstaza, eladocagene exuparvovec, Date of authorisation: 18/07/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0